AktiVax
Broomfield · Founded 2008
About AktiVax
AktiVaxTM is creating a paradigm shift in vaccine delivery that will solve vaccine partners’ problems, costs, and complexities by providing an alternative to the traditional syringe and vial system. AktiVax’s solution involves a three-pillared approach: expertise in cost-effective, dry vaccine formulation; differentiated delivery devices; and efficient manufacturing for rapid market distribution. Our proposition has already attracted a number of vaccine partners representing a significant portion of the $30 billion vaccine industry. We believe that our solution will create a new standard of care in the vaccine market.
Company Facts
- Founded: 2008
- Legal name: Aktivax, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $515.3K
- Last round: Debt Financing (Mar 2012)
- Website: aktivax.com
- Phone: 7208594101
Social Profiles
Canonical: https://fsome.com/organization/aktivax-8305546 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.